Rang	Name	Position
1	Mr. Robert A. Michael CPA	CEO & Chairman of the Board
2	Mr. Scott T. Reents	Executive VP & CFO
3	Dr. Azita Saleki-Gerhardt Ph.D.	Executive VP & COO
4	Dr. Roopal B. Thakkar M.D.	Executive VP of Research & Development and Chief Scientific Officer
5	Mr. Jeffrey Ryan Stewart	Executive VP & Chief Commercial Officer
6	Ms. Linda Ray	Senior VP & Chief Information Officer
7	Ms. Elizabeth Shea	Senior Vice President of Investor Relations
8	Mr. Perry C. Siatis	Executive VP, General Counsel & Secretary
9	Mr. Demetris D. Crum	Executive VP & Chief Human Resources Officer
10	Mr. Wulff-Erik von Borcke	Senior VP & President of Oncology

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	10,23%	47,60 Mrd. USD
2	BlackRock Inc	8,53%	39,68 Mrd. USD
3	Vanguard Capital Management, LLC	6,50%	30,25 Mrd. USD
4	State Street Corp	4,60%	21,39 Mrd. USD
5	JPMorgan Chase & Co	3,21%	14,94 Mrd. USD
6	Vanguard Portfolio Management, LLC	2,80%	13,04 Mrd. USD
7	Geode Capital Management, LLC	2,65%	12,31 Mrd. USD
8	Morgan Stanley - Brokerage Accounts	2,15%	10,01 Mrd. USD
9	Capital Research Global Investors	1,77%	8,23 Mrd. USD
10	NORGES BANK	1,45%	6,76 Mrd. USD
11	Bank of America Corp	1,35%	6,30 Mrd. USD
12	FMR Inc	1,23%	5,73 Mrd. USD
13	Northern Trust Corp	1,20%	5,59 Mrd. USD
14	Capital World Investors	0,90%	4,17 Mrd. USD
15	The Goldman Sachs Group Inc	0,86%	3,99 Mrd. USD
16	Franklin Resources Inc	0,82%	3,83 Mrd. USD
17	Capital Research & Mgmt Co - Division 3	0,82%	3,80 Mrd. USD
18	UBS Asset Mgmt Americas Inc	0,80%	3,73 Mrd. USD
19	UBS Group AG	0,80%	3,70 Mrd. USD
20	Bank of New York Mellon Corp	0,75%	3,50 Mrd. USD